Company Overview and News

Podcast | Sensex snaps 5-day losing streak; Nifty closes below 100-DMA

22h moneycontrol
The S&P BSE Sensex snapped its 5-day losing streak and closed in positive making a small bullish candle on the daily candlestick charts on Tuesday. The Nifty50 also held on to its crucial support level placed at 10,500 levels, but closed below its 100-days moving average placed around 10,540.

HC asks Axis Bank to renew RCom bank guarantees

2018-05-21 livemint
New Delhi:The Delhi high court on Monday directed Axis Bank to renew all pending bank guarantees with respect to Reliance Communications Ltd (RCom), whether expired or yet to expire, as an interim measure.

Market Live: Sensex falls 200 pts, Midcap underperforms; Avenue Supermarts dips further

2018-05-21 moneycontrol
Buzzing: Shares of Dilip Buildcon fell 5.6 percent intraday as company's promoters pledged their shares with RBL Bank.

Market Live: Nifty struggles below 10,600, Midcap index extends losses; PSU banks gain

2018-05-21 moneycontrol
Buzzing: Shares of Indoco Remedies rose over 4 percent as USFDA has successfully completed the inspection at its manufacturing facilities.

Market Live: Sensex rebounds, Nifty above 10,600; Amara Raja, Century Textiles plunge

2018-05-21 moneycontrol
Pre-Opening Rate: Indostar Capital Finance share price settled at Rs 600 on the National Stock Exchange, up 4.9 percent compared to issue price of Rs 572.

Axis Bank Limited - Analysts/Institutional Investor Meet/Con. Call Updates

2018-05-18 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.

Financials, higher crude pull Sensex down 301 pts, Nifty below 10,600; Bajaj Finance up 4%

2018-05-18 moneycontrol
Benchmark indices extended losses for fourth consecutive session on Thursday, weighed by banking & financials, metals, infra and oil stocks.

After heavy losses, banks focus on being capital-light, reorient business models to push growth

2018-05-18 moneycontrol
The rise in bad loans and subdued corporate demand is driving banks to explore new business models, cross-sell products with more retail-oriented segments for growth. They are stepping up credit monitoring standards to lend to good quality customers.

Market Live: Sensex, Nifty Bank slip over 100 pts; HUL pips ITC in market cap

2018-05-18 moneycontrol
Fund Raising: Infrastructure firm NCC said its board will meet next week to consider raising funds through issuance of equity shares or warrants to promoters on preferential basis.

Sensex extends losses on foreign fund outflows, rising oil prices

Mumbai: The BSE Sensex drifted lower by another 125 points in early trade today amid unabated foreign fund outflows and surging global crude oil prices. The rupee depreciating against the US dollar also affected momentum.

Market Live: Sensex down over 100 pts; Bajaj Fin extends gains, Bajaj Auto top gainer

2018-05-18 moneycontrol
Market Update: The market continued trade lower, with the Sensex falling more than 100 points amid higher crude oil prices and corporate earnings.

Market Live: Sensex breaks 35K, down over 150 pts; all sectoral indices in the red

2018-05-18 moneycontrol
Market Update: The market extended opening losses, continuing correction for the fourth consecutive session amid higher crude oil prices, weak rupee.

Tata Steel said to seek loan for Bhushan Steel asset purchase

2018-05-17 livemint
Mumbai: Tata Steel Ltd. is preparing a Rs11,500 crore ($1.7 billion) loan to help fund its purchase of assets from Bhushan Steel Ltd., people familiar with the matter said.

Brent crude at $80/bbl drags Sensex 239 pts, Nifty below 10,700 but Midcap index outperforms

2018-05-17 moneycontrol
Benchmark indices extended losses for third consecutive session on Thursday, with the Sensex falling more than 200 points after Brent crude oil futures crossed USD 80 a barrel that will hit the central government's fiscal balance.

Related Articles

ANTH: Anthera Pharmaceuticals Analysis and Research Report

2018-05-21 - Asif

Overview Anthera Pharmaceuticals, Inc. is a biopharmaceutical company focused on advancing the development and commercialization of innovative medicines that benefit patients with unmet medical needs. The company currently have two compounds in development, Sollpura and blisibimod. The company licensed Sollpura from Eli Lilly & Co (“Eli Lilly”) in July 2014. Sollpura is a novel non-porcine investigational Pancreatic Enzyme Replacement Therapy (“PERT”) intended for the treatment of patients with Exocrine Pancreatic Insufficiency (“EPI”), often seen in patients with cystic fibrosis and other conditions. The company licensed blisibimod from Amgen, Inc. (“Amgen”) in December 2007. Blisibimod targets B-cell activating factor, or BAFF, which has been shown to be elevated in a variety of B-cell mediated autoimmune diseases, including Immunoglobulin A nephropathy, or IgA nephropathy. Sollpura The exocrine pancreas is responsible for synthesis and secretion of digestive en...

AGEN: Agenus Inc Analysis and Research Report

2018-05-21 - Asif

Business Agenus is a clinical-stage immuno-oncology (“I-O”) company dedicated to becoming a leader in the discovery and development of innovative combination therapies and committed to bringing effective medicines to patients with cancer. The company's business is designed to drive success in I-O through speed, innovation, and effective combination therapies. Agenus has assembled fully integrated capabilities from novel target discovery, antibody generation, cell line development, and good manufacturing practice (“GMP”) manufacturing together with a comprehensive portfolio consisting of antibody-based therapeutics, adjuvants and cancer vaccine platforms. The company leverage its immune biology platforms to identify effective combination therapies for development and have developed productive partnerships to advance its innovation. The company believe the next generation of cancer treatment will build on clinically validated antibodies targeting CTLA-4 and PD-1 combined wi...

SQ: Square Analysis and Research Report

2018-05-21 - Asif

Business The company started Square in February 2009 to enable businesses (sellers) to accept card payments, an important capability that was previously inaccessible to many businesses. However, sellers also need innovative solutions to thrive, and Square has since expanded to provide additional products and services to give these businesses access to the same tools as large businesses. This approach aligns with its purpose of economic empowerment, as everything the company do should give sellers accessible, affordable tools to grow their businesses and participate in the economy. Square is a cohesive commerce ecosystem that helps its sellers start, run, and grow their businesses. The company combine sophisticated software with affordable hardware to enable sellers to turn mobile and computing devices into powerful payment and point-of-sale solutions. Square has high seller acceptance rates and fast onboarding, while maintaining low risk and fraud losses as a result of its a...